Frontiers in Immunology (Jan 2023)
Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas
- Claudia Carenza,
- Claudia Carenza,
- Sara Franzese,
- Sara Franzese,
- Alessandra Castagna,
- Sara Terzoli,
- Sara Terzoli,
- Matteo Simonelli,
- Matteo Simonelli,
- Pasquale Persico,
- Pasquale Persico,
- Lorenzo Bello,
- Lorenzo Bello,
- Marco Conti Nibali,
- Federico Pessina,
- Federico Pessina,
- Paolo Kunderfranco,
- Clelia Peano,
- Simone Balin,
- Simone Balin,
- Joanna Mikulak,
- Francesca Calcaterra,
- Francesca Calcaterra,
- Raffaella Bonecchi,
- Raffaella Bonecchi,
- Benedetta Savino,
- Benedetta Savino,
- Massimo Locati,
- Massimo Locati,
- Silvia Della Bella,
- Silvia Della Bella,
- Domenico Mavilio,
- Domenico Mavilio
Affiliations
- Claudia Carenza
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Claudia Carenza
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Sara Franzese
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Sara Franzese
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Alessandra Castagna
- Laboratory of Leukocyte Biology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Sara Terzoli
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Sara Terzoli
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
- Matteo Simonelli
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
- Matteo Simonelli
- Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Pasquale Persico
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
- Pasquale Persico
- Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Lorenzo Bello
- Unit of Oncological Neurosurgery, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy
- Lorenzo Bello
- Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
- Marco Conti Nibali
- Unit of Oncological Neurosurgery, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy
- Federico Pessina
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
- Federico Pessina
- Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Paolo Kunderfranco
- Bioinformatics Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Clelia Peano
- 0Institute of Genetic and Biomedical Research, UoS Milan, National Research Council, Rozzano, Milan, Italy
- Simone Balin
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Simone Balin
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Joanna Mikulak
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Francesca Calcaterra
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Francesca Calcaterra
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Raffaella Bonecchi
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
- Raffaella Bonecchi
- 1Laboratory of Chemokine Biology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Benedetta Savino
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Benedetta Savino
- Laboratory of Leukocyte Biology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Massimo Locati
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Massimo Locati
- Laboratory of Leukocyte Biology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Silvia Della Bella
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Silvia Della Bella
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Domenico Mavilio
- Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy
- Domenico Mavilio
- Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- DOI
- https://doi.org/10.3389/fimmu.2022.1074762
- Journal volume & issue
-
Vol. 13
Abstract
IntroductionAdult-type diffuse gliomas are malignant primary brain tumors characterized by very poor prognosis. Dendritic cells (DCs) are key in priming antitumor effector functions in cancer, but their role in gliomas remains poorly understood.MethodsIn this study, we characterized tumor-infiltrating DCs (TIDCs) in adult patients with newly diagnosed diffuse gliomas by using multi-parametric flow cytometry and single-cell RNA sequencing.ResultsWe demonstrated that different subsets of DCs are present in the glioma microenvironment, whereas they are absent in cancer-free brain parenchyma. The largest cluster of TIDCs was characterized by a transcriptomic profile suggestive of severe functional impairment. Patients undergoing perioperative corticosteroid treatment showed a significant reduction of conventional DC1s, the DC subset with key functions in antitumor immunity. They also showed phenotypic and transcriptional evidence of a more severe functional impairment of TIDCs.DiscussionOverall, the results of this study indicate that functionally impaired DCs are recruited in the glioma microenvironment. They are severely affected by dexamethasone administration, suggesting that the detrimental effects of corticosteroids on DCs may represent one of the mechanisms contributing to the already reported negative prognostic impact of steroids on glioma patient survival.
Keywords
- dendritic cells
- brain tumors
- perioperative corticosteroids
- immune suppressive tumor microenvironment
- single cell-RNA sequencing